NADAC acquisition cost data for SOTALOL AF 80 MG TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 42806012101 | $0.0765 | 2022-12-21 | Rx |
| 60505022201 | $0.0765 | 2022-12-21 | Rx |
| 76385012501 | $0.0765 | 2022-12-21 | Rx |
| 42806012101 | $0.0765 | 2022-12-21 | Rx |
| 60505022201 | $0.0765 | 2022-12-21 | Rx |
| 76385012501 | $0.0765 | 2022-12-21 | Rx |
Generic: Sotalol HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $35.5M | 1,198,966 | 266,455 | $0.2653 |
| 2020 | $35.5M | 1,170,107 | 263,287 | $0.2579 |
| 2021 | $28.9M | 1,129,877 | 265,678 | $0.2120 |
| 2022 | $27.4M | 1,098,507 | 263,534 | $0.2039 |
| 2023 | $30.0M | 1,081,671 | 262,533 | $0.2236 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| Florida | $2.7M | 92,412 | 25,078 |
| California | $2.3M | 78,276 | 21,545 |
| Ohio | $1.9M | 57,527 | 14,001 |
| Texas | $1.9M | 71,171 | 18,577 |
| Pennsylvania | $1.4M | 53,368 | 12,229 |
| Tennessee | $1.2M | 46,504 | 11,678 |
| Georgia | $1.1M | 42,650 | 10,621 |
| New York | $962.1K | 35,937 | 9,425 |
| Michigan | $947.8K | 33,925 | 9,113 |
| North Carolina | $912.1K | 35,485 | 8,593 |
| Minnesota | $899.1K | 26,355 | 7,188 |
| Illinois | $861.8K | 27,624 | 7,068 |
| Missouri | $854.5K | 31,435 | 7,389 |
| Indiana | $814.6K | 25,699 | 6,544 |
| Arkansas | $788.5K | 31,225 | 6,438 |
| Kentucky | $774.5K | 27,368 | 6,316 |
| Arizona | $765.4K | 25,828 | 7,483 |
| Alabama | $698.4K | 22,211 | 5,629 |
| Louisiana | $645.0K | 32,426 | 7,339 |
| New Jersey | $612.4K | 20,300 | 5,451 |
| Kansas | $558.8K | 20,764 | 4,777 |
| Virginia | $529.3K | 17,532 | 4,625 |
| South Carolina | $528.5K | 20,163 | 5,152 |
| Massachusetts | $522.3K | 18,704 | 4,877 |
| Wisconsin | $516.1K | 16,228 | 4,210 |
| Iowa | $484.7K | 23,156 | 4,998 |
| Washington | $408.4K | 15,110 | 4,102 |
| Mississippi | $335.4K | 15,321 | 3,596 |
| Connecticut | $316.5K | 9,930 | 2,531 |
| Colorado | $269.0K | 9,362 | 2,652 |
| Oregon | $260.0K | 8,526 | 2,301 |
| Nebraska | $249.8K | 10,914 | 2,147 |
| Oklahoma | $247.2K | 8,083 | 1,957 |
| Utah | $223.9K | 8,773 | 2,434 |
| West Virginia | $213.0K | 9,648 | 2,440 |
| Maryland | $186.5K | 6,495 | 1,833 |
| Idaho | $181.6K | 7,944 | 2,166 |
| Maine | $166.4K | 4,854 | 1,306 |
| Nevada | $122.6K | 4,567 | 1,385 |
| New Hampshire | $117.6K | 3,730 | 1,051 |
| South Dakota | $103.7K | 4,611 | 951 |
| Rhode Island | $78.6K | 2,606 | 702 |
| New Mexico | $72.1K | 2,502 | 762 |
| North Dakota | $66.5K | 2,736 | 678 |
| Montana | $58.8K | 2,693 | 703 |
| Delaware | $55.9K | 1,641 | 490 |
| Puerto Rico | $54.9K | 2,783 | 545 |
| Vermont | $35.3K | 1,140 | 306 |
| Wyoming | $27.8K | 937 | 275 |
| Hawaii | $27.2K | 1,045 | 330 |
| District of Columbia | $19.6K | 613 | 211 |
| Alaska | $7.0K | 252 | 76 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.
Explore More Data Tools
For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.